Humacyte (HUMA) Common Equity (2020 - 2026)
Humacyte (HUMA) reported Common Equity of $31.26 million for Q2 2026, up 671.5% from $4.05 million a year earlier and up 168.9% from the prior quarter.
Powered by 
Analysis
Humacyte (HUMA) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Humacyte posted Common Equity of $3.11 million.
- By year, Common Equity came in at -$52.67 million in FY2024, $13.55 million in FY2023 (-88.4%), $116.93 million in FY2022 (-4.3%) and $122.17 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Common Equity since Q1 2025.
- The high point for year-over-year Common Equity in five years was Q2 2026 (growth of 671.5%); the low point was Q4 2023 (a decline of 88.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $11.62 million (Q1 2026), $3.11 million (Q4 2025) and -$4.75 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Humacyte | 147.23 Mn | 147.23 Mn | -825,000.00 | 31.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.26 Mn |
| Mar 31, 2026 | 11.62 Mn |
| Dec 31, 2025 | 3.11 Mn |
| Sep 30, 2025 | -4.75 Mn |
| Jun 30, 2025 | 4.05 Mn |
| Mar 31, 2025 | 36.04 Mn |
| Dec 31, 2024 | -52.67 Mn |
| Sep 30, 2024 | -63.72 Mn |
| Jun 30, 2024 | -28.29 Mn |
| Mar 31, 2024 | 26.15 Mn |
| Dec 31, 2023 | 13.55 Mn |
| Sep 30, 2023 | 36.99 Mn |
| Jun 30, 2023 | 61.12 Mn |
| Mar 31, 2023 | 81.89 Mn |
| Dec 31, 2022 | 116.93 Mn |
| Sep 30, 2022 | 118.67 Mn |
| Jun 30, 2022 | 142.26 Mn |
| Mar 31, 2022 | 103.89 Mn |
| Dec 31, 2021 | 122.17 Mn |
| Sep 30, 2021 | 75.86 Mn |
API Access
Humacyte Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=HUMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "HUMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=HUMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();